FDA Issues Warning For Over-The-Counter Diarrhea Drug

Law360, New York (September 18, 2012, 6:28 PM EDT) -- The U.S. Food and Drug Administration on Tuesday warned consumers not to use Intestinomicina, a drug marketed as a treatment for diarrhea and gastrointestinal infections, because it contains chloramphenicol, the oral form of which is banned in the U.S.

Intestinomicina, available as an over-the-counter treatment, contains the prescription drug ingredient, chloramphenicol. Oral forms of chloramphenicol were formally withdrawn from the U.S. market in July due to the risk of serious and life-threatening injuries, according to the FDA.

Intestinomicina is labeled primarily in Spanish and lists the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.